ClinVar Genomic variation as it relates to human health
NM_000251.3(MSH2):c.2201C>T (p.Ser734Phe)
The aggregate germline classification for this variant, typically for a monogenic or Mendelian disorder as in the ACMG/AMP guidelines, or for response to a drug. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the aggregate classification.
Stars represent the aggregate review status, or the level of review supporting the aggregate germline classification for this VCV record. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. The number of submissions which contribute to this review status is shown in parentheses.
No data submitted for somatic clinical impact
No data submitted for oncogenicity
Variant Details
- Identifiers
-
NM_000251.3(MSH2):c.2201C>T (p.Ser734Phe)
Variation ID: 2155059 Accession: VCV002155059.2
- Type and length
-
single nucleotide variant, 1 bp
- Location
-
Cytogenetic: 2p21 2: 47476562 (GRCh38) [ NCBI UCSC ] 2: 47703701 (GRCh37) [ NCBI UCSC ]
- Timeline in ClinVar
-
First in ClinVar Help The date this variant first appeared in ClinVar with each type of classification.
Last submission Help The date of the most recent submission for each type of classification for this variant.
Last evaluated Help The most recent date that a submitter evaluated this variant for each type of classification.
Germline Feb 8, 2023 Feb 20, 2024 Sep 1, 2022 - HGVS
-
Nucleotide Protein Molecular
consequenceNM_000251.3:c.2201C>T MANE Select Help Transcripts from the Matched Annotation from the NCBI and EMBL-EBI (MANE) collaboration.
NP_000242.1:p.Ser734Phe missense NM_001258281.1:c.2003C>T NP_001245210.1:p.Ser668Phe missense NM_001406631.1:c.2201C>T NP_001393560.1:p.Ser734Phe missense NM_001406632.1:c.2201C>T NP_001393561.1:p.Ser734Phe missense NM_001406633.1:c.2201C>T NP_001393562.1:p.Ser734Phe missense NM_001406634.1:c.2201C>T NP_001393563.1:p.Ser734Phe missense NM_001406635.1:c.2201C>T NP_001393564.1:p.Ser734Phe missense NM_001406636.1:c.2168C>T NP_001393565.1:p.Ser723Phe missense NM_001406637.1:c.2201C>T NP_001393566.1:p.Ser734Phe missense NM_001406638.1:c.2240C>T NP_001393567.1:p.Ser747Phe missense NM_001406639.1:c.2201C>T NP_001393568.1:p.Ser734Phe missense NM_001406640.1:c.2201C>T NP_001393569.1:p.Ser734Phe missense NM_001406641.1:c.2201C>T NP_001393570.1:p.Ser734Phe missense NM_001406642.1:c.2201C>T NP_001393571.1:p.Ser734Phe missense NM_001406643.1:c.2201C>T NP_001393572.1:p.Ser734Phe missense NM_001406644.1:c.2201C>T NP_001393573.1:p.Ser734Phe missense NM_001406645.1:c.2201C>T NP_001393574.1:p.Ser734Phe missense NM_001406646.1:c.2201C>T NP_001393575.1:p.Ser734Phe missense NM_001406647.1:c.2051C>T NP_001393576.1:p.Ser684Phe missense NM_001406648.1:c.2201C>T NP_001393577.1:p.Ser734Phe missense NM_001406649.1:c.2051C>T NP_001393578.1:p.Ser684Phe missense NM_001406650.1:c.2051C>T NP_001393579.1:p.Ser684Phe missense NM_001406651.1:c.2051C>T NP_001393580.1:p.Ser684Phe missense NM_001406652.1:c.2051C>T NP_001393581.1:p.Ser684Phe missense NM_001406653.1:c.2141C>T NP_001393582.1:p.Ser714Phe missense NM_001406654.1:c.1781C>T NP_001393583.1:p.Ser594Phe missense NM_001406656.1:c.1304C>T NP_001393585.1:p.Ser435Phe missense NM_001406658.1:c.845C>T NP_001393587.1:p.Ser282Phe missense NM_001406659.1:c.845C>T NP_001393588.1:p.Ser282Phe missense NM_001406660.1:c.845C>T NP_001393589.1:p.Ser282Phe missense NM_001406661.1:c.845C>T NP_001393590.1:p.Ser282Phe missense NM_001406662.1:c.845C>T NP_001393591.1:p.Ser282Phe missense NM_001406669.1:c.845C>T NP_001393598.1:p.Ser282Phe missense NM_001406674.1:c.2201C>T NP_001393603.1:p.Ser734Phe missense NR_176230.1:n.2237C>T NR_176231.1:n.2237C>T NR_176232.1:n.2237C>T NR_176233.1:n.2079C>T NR_176234.1:n.2237C>T NR_176235.1:n.2237C>T NR_176236.1:n.2237C>T NR_176237.1:n.2237C>T NR_176238.1:n.2370C>T NR_176239.1:n.2237C>T NR_176241.1:n.2237C>T NR_176242.1:n.2237C>T NR_176243.1:n.2087C>T NR_176244.1:n.2237C>T NR_176245.1:n.2237C>T NR_176246.1:n.2237C>T NR_176247.1:n.2237C>T NR_176248.1:n.2237C>T NR_176249.1:n.2467C>T NR_176250.1:n.1977C>T NC_000002.12:g.47476562C>T NC_000002.11:g.47703701C>T NG_007110.2:g.78439C>T LRG_218:g.78439C>T LRG_218t1:c.2201C>T LRG_218p1:p.Ser734Phe - Protein change
- S435F, S668F, S747F, S594F, S723F, S734F, S714F, S282F, S684F
- Other names
- -
- Canonical SPDI
- NC_000002.12:47476561:C:T
-
Functional
consequence HelpThe effect of the variant on RNA or protein function, based on experimental evidence from submitters.
- -
-
Global minor allele
frequency (GMAF) HelpThe global minor allele frequency calculated by the 1000 Genomes Project. The minor allele at this location is indicated in parentheses and may be different from the allele represented by this VCV record.
- -
-
Allele frequency
Help
The frequency of the allele represented by this VCV record.
- -
- Links
Genes
Gene | OMIM | ClinGen Gene Dosage Sensitivity Curation |
Variation Viewer
Help
Links to Variation Viewer, a genome browser to view variation data from NCBI databases. |
Related variants | ||
---|---|---|---|---|---|---|
HI score
Help
The haploinsufficiency score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
TS score
Help
The triplosensitivity score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
Within gene
Help
The number of variants in ClinVar that are contained within this gene, with a link to view the list of variants. |
All
Help
The number of variants in ClinVar for this gene, including smaller variants within the gene and larger CNVs that overlap or fully contain the gene. |
|||
MSH2 | Sufficient evidence for dosage pathogenicity | No evidence available |
GRCh38 GRCh37 |
7404 | 7566 |
Conditions - Germline
Condition
Help
The condition for this variant-condition (RCV) record in ClinVar. |
Classification
Help
The aggregate germline classification for this variant-condition (RCV) record in ClinVar. The number of submissions that contribute to this aggregate classification is shown in parentheses. (# of submissions) |
Review status
Help
The aggregate review status for this variant-condition (RCV) record in ClinVar. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. |
Last evaluated
Help
The most recent date that a submitter evaluated this variant for the condition. |
Variation/condition record
Help
The RCV accession number, with most recent version number, for the variant-condition record, with a link to the RCV web page. |
---|---|---|---|---|
Uncertain significance (1) |
criteria provided, single submitter
|
Sep 1, 2022 | RCV003072139.3 |
Submissions - Germline
Classification
Help
The submitted germline classification for each SCV record. (Last evaluated) |
Review status
Help
Stars represent the review status, or the level of review supporting the submitted (SCV) record. This value is calculated by NCBI based on data from the submitter. Read our rules for calculating the review status. This column also includes a link to the submitter’s assertion criteria if provided, and the collection method. (Assertion criteria) |
Condition
Help
The condition for the classification, provided by the submitter for this submitted (SCV) record. This column also includes the affected status and allele origin of individuals observed with this variant. |
Submitter
Help
The submitting organization for this submitted (SCV) record. This column also includes the SCV accession and version number, the date this SCV first appeared in ClinVar, and the date that this SCV was last updated in ClinVar. |
More information
Help
This column includes more information supporting the classification, including citations, the comment on classification, and detailed evidence provided as observations of the variant by the submitter. |
|
---|---|---|---|---|---|
Uncertain significance
(Sep 01, 2022)
|
criteria provided, single submitter
Method: clinical testing
|
Hereditary nonpolyposis colorectal neoplasms
Affected status: unknown
Allele origin:
germline
|
Labcorp Genetics (formerly Invitae), Labcorp
Accession: SCV003465732.2
First in ClinVar: Feb 07, 2023 Last updated: Feb 20, 2024 |
Comment:
This variant has not been reported in the literature in individuals affected with MSH2-related conditions. In summary, the available evidence is currently insufficient to determine … (more)
This variant has not been reported in the literature in individuals affected with MSH2-related conditions. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of experimental studies (such as gene expression, population dynamics, functional pathways, and cell-cycle effects in cell culture) performed at Invitae indicates that this missense variant is not expected to disrupt MSH2 protein function. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces serine, which is neutral and polar, with phenylalanine, which is neutral and non-polar, at codon 734 of the MSH2 protein (p.Ser734Phe). (less)
|
Germline Functional Evidence
There is no functional evidence in ClinVar for this variation. If you have generated functional data for this variation, please consider submitting that data to ClinVar. |
Citations for germline classification of this variant
HelpThere are no citations for germline classification of this variant in ClinVar. If you know of citations for this variation, please consider submitting that information to ClinVar. |
Text-mined citations for this variant ...
HelpRecord last updated Sep 29, 2024
This date represents the last time this VCV record was updated. The update may be due to an update to one of the included submitted records (SCVs), or due to an update that ClinVar made to the variant such as adding HGVS expressions or a rs number. So this date may be different from the date of the “most recent submission” reported at the top of this page.